drugset / Trial / NCT00601835
Canadian Manufactured Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine Compared With U.S. Manufactured Td
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To compare the seroprotection rates and booster responses to Canadian-manufactured Tetanus and Diphtheria Toxoids Adsorbed vaccine to the seroprotection rates and booster responses to the US-manufactured Tetanus and Diphtheria Toxoids Adsorbed vaccine when administered to subjects ≥ 60 years of age. To compare the post-vaccination geometric mean titers of antibody (GMTs) to Canadian manufactured Tetanus and Diphtheria Toxoids Adsorbed vaccine to the post-vaccination GMTs to the US manufactured Tetanus and Diphtheria Toxoids Adsorbed vaccine when administered to subjects ≥ 60 years of age.
Timeline
- Start
- 2004-05
- Primary completion
- 2005-07
- Completion
- 2005-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Tetanus and Diphtheria Toxoids Adsorbed (Td) Vaccine | Vaccine | 0.5 ml | Intramuscular |